Personal information

Countries

Germany

Activities

Collapse all

Works (19)

Data from Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542680.v1
Contributors: Alexander Rau; Wolfgang S. Lieb; Oliver Seifert; Jonas Honer; Dennis Birnstock; Fabian Richter; Nadine Aschmoneit; Monilola A. Olayioye; Roland E. Kontermann
Source: check_circle
Crossref

Data from Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6542680
Contributors: Alexander Rau; Wolfgang S. Lieb; Oliver Seifert; Jonas Honer; Dennis Birnstock; Fabian Richter; Nadine Aschmoneit; Monilola A. Olayioye; Roland E. Kontermann
Source: check_circle
Crossref

Data from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543369
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Data from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.c.6543369.v1
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Data from Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22520554
Contributors: Alexander Rau; Wolfgang S. Lieb; Oliver Seifert; Jonas Honer; Dennis Birnstock; Fabian Richter; Nadine Aschmoneit; Monilola A. Olayioye; Roland E. Kontermann
Source: check_circle
Crossref

Supplementary Data from Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22520554.v1
Contributors: Alexander Rau; Wolfgang S. Lieb; Oliver Seifert; Jonas Honer; Dennis Birnstock; Fabian Richter; Nadine Aschmoneit; Monilola A. Olayioye; Roland E. Kontermann
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522413.v1
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522407
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522401.v1
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522404.v1
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522413
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522401
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522407.v1
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Supplementary Figure from Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

2023-04-03 | Preprint
DOI: 10.1158/1535-7163.22522404
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer

Molecular Cancer Therapeutics
2022-05-04 | Journal article
DOI: 10.1158/1535-7163.MCT-21-0818
Contributors: Alexander Rau; Nicole Janssen; Lennart Kühl; Thomas Sell; Svetlana Kalmykova; Thomas E. Mürdter; Marc-H. Dahlke; Christine Sers; Markus Morkel; Matthias Schwab et al.
Source: check_circle
Crossref

A bivalent, bispecific Dab-Fc antibody molecule for dual targeting of HER2 and HER3

mAbs
2021-01-01 | Journal article
DOI: 10.1080/19420862.2021.1902034
Contributors: Alexander Rau; Katharina Kocher; Mirjam Rommel; Lennart Kühl; Maximilian Albrecht; Hannes Gotthard; Nadine Aschmoneit; Bettina Noll; Monilola A. Olayioye; Roland E. Kontermann et al.
Source: check_circle
Crossref

Inhibition of Tumor Cell Growth and Cancer Stem Cell Expansion by a Bispecific Antibody Targeting EGFR and HER3

Molecular Cancer Therapeutics
2020-07-01 | Journal article
DOI: 10.1158/1535-7163.MCT-19-1095
Contributors: Alexander Rau; Wolfgang S. Lieb; Oliver Seifert; Jonas Honer; Dennis Birnstock; Fabian Richter; Nadine Aschmoneit; Monilola A. Olayioye; Roland E. Kontermann
Source: check_circle
Crossref

Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules

mAbs
2019-07-04 | Journal article
DOI: 10.1080/19420862.2019.1603024
Contributors: Oliver Seifert; Alexander Rau; Nadine Beha; Fabian Richter; Roland E. Kontermann
Source: check_circle
Crossref

Inhibition of HER3 activation and tumor growth with a human antibody binding to a conserved epitope formed by domain III and IV.

2017-04 | Journal article
DOI: 10.1080/19420862.2017.1319023
PMID: 28421882
Contributors: Schmitt LC; Rau A; Seifert O; Honer J; Hutt M; Schmid S; Zantow J; Hust M; Dübel S; Olayioye MA et al.
Source: Self-asserted source
Alexander Rau via Europe PubMed Central
How many people are using ORCID?